0.1.0 - ci-build
AGESMedicinalProductR5 - Local Development build (v0.1.0) built by the FHIR (HL7® FHIR® Standard) Build Tools. See the Directory of published versions
version: 2.0.0+20240208; Last updated: 2025-06-25 17:17:45+0200
Bundle asp-liste-8 of type collection
Entry 1 - fullUrl = MedicinalProductDefinition/100406362
Resso}:
identifier:
https://www.ages.at/fhir/referenceNumber
/100406362domain: Human
combinedPharmaceuticalDoseForm: Injektionsdispersion
legalStatusOfSupply: Arzneimittel zur einmaligen Abgabe auf aerztliche Verschreibung
classification: COVID-19-mRNA-Impfstoff
Names
ProductName Comirnaty 30 Mikrogramm/Dosis Injektionsdispersion; COVID-19-mRNA-Impfstoff (Nukleosid-modifiziert)
Entry 2 - fullUrl = PackagedProductDefinition/5506359
Resso}:
identifier:
http://ema.europa.eu/fhir/dataCarrierIdentifier
/5506359packageFor: Bundle: identifier = 1.2.40.0.34.4.16; type = collection
containedItemQuantity: 1.0 Durchstechflasche (Details: unitsOfPresentation code200000002158 = '200000002158')
MarketingStatuses
Status Keine Daten übermittelt Packagings
Type Durchstechflasche
Entry 3 - fullUrl = RegulatedAuthorization/EU/1/20/1528/002-003,013
Resso}:
identifier:
http://ema.europa.eu/fhir/marketingAuthorizationNumber
/EU/1/20/1528/002-003,013subject: Bundle: identifier = 1.2.40.0.34.4.16; type = collection
status: Surrendered
holder:
Biontech Manufacturing GmbH
Entry 4 - fullUrl = AdministrableProductDefinition/2031677
Resso}:
identifier:
http://ema.europa.eu/fhir/???
/2031677formOf: Bundle: identifier = 1.2.40.0.34.4.16; type = collection
RouteOfAdministrations
Code intramuskuläre Anwendung
Entry 5 - fullUrl = Ingredient/22582997
Resso}:
identifier:
http://ema.europa.eu/fhir/???
/22582997for: Bundle: identifier = 1.2.40.0.34.4.16; type = collection
role: Wirkstoff
substance
Codes
Concept TOZINAMERAN Strengths
Presentation[x] 30.0 µg (Details: Units Of Measurement code100000110656 = 'microgram(s)')/1.0 Durchstechflasche (Details: Units Of Presentation code200000002158 = 'Durchstechflasche')